Webinar: Agonist Antibodies - Reprogramming Immunity: Designing Smarter Checkpoint Receptor Agonists
Eurofins DiscoverX
Webinar: Agonist Antibodies - Reprogramming Immunity: Designing Smarter Checkpoint Receptor Agonists
48:44
Webinar: Advancing Obesity Drug Discovery: Cell-based Assays for GLP 1 and the G Suite
Eurofins DiscoverX
Webinar: Advancing Obesity Drug Discovery: Cell-based Assays for GLP 1 and the G Suite
55:40
EDRX Webinar The value of GPCR cell based assays in drug discovery
Eurofins DiscoverX
EDRX Webinar The value of GPCR cell based assays in drug discovery
59:46
Ion Channel Drug Discovery Webinar - Recent Advances in Novel Non-opioid Pain research
Eurofins DiscoverX
Ion Channel Drug Discovery Webinar - Recent Advances in Novel Non-opioid Pain research
59:17
Advancing Therapeutics Targeting Cytokines with Functional Cell-based Assays
Eurofins DiscoverX
Advancing Therapeutics Targeting Cytokines with Functional Cell-based Assays
34:55
Functional Assays for the Development of Agonistic Antibodies
Eurofins DiscoverX
Functional Assays for the Development of Agonistic Antibodies
51:34
Accelerating Immuno-Oncology Drug Discovery with MOA-Reflective, Functional Cell-Based Assays
Eurofins DiscoverX
Accelerating Immuno-Oncology Drug Discovery with MOA-Reflective, Functional Cell-Based Assays
30:23
Webinar - Validated Bioassays for Accelerating GLP 1 & -2 Therapeutics
Eurofins DiscoverX
Webinar - Validated Bioassays for Accelerating GLP 1 & -2 Therapeutics
59:06
Roundtable- Accelerating your therapeutics development with bioassays
Eurofins DiscoverX
Roundtable- Accelerating your therapeutics development with bioassays
57:52
Cytotoxicity Bioassay Webinar
Eurofins DiscoverX
Cytotoxicity Bioassay Webinar
46:40
EDRX GPCR Assays
Eurofins DiscoverX
EDRX GPCR Assays
5:06
Novel small molecule inhibitors of oncogenic SHP2 variants characterized by target engagement
Eurofins DiscoverX
Novel small molecule inhibitors of oncogenic SHP2 variants characterized by target engagement
1:04:04
Unlocking Orphan GPCRs with an Innovative Forward Trafficking Approach
Eurofins DiscoverX
Unlocking Orphan GPCRs with an Innovative Forward Trafficking Approach
1:15:29
Automating Functional Cell-Based Bioassays: Assay Performance for Potency Testing Programs
Eurofins DiscoverX
Automating Functional Cell-Based Bioassays: Assay Performance for Potency Testing Programs
40:38
SPRINTer Platform: Detection of Endogenous Protein Turnover Induced by Targeted Degraders
Eurofins DiscoverX
SPRINTer Platform: Detection of Endogenous Protein Turnover Induced by Targeted Degraders
5:25
Eurofins Discovery PEGS Conference 2021 Therapeutic Interventions for COVID-19
Eurofins DiscoverX
Eurofins Discovery PEGS Conference 2021 Therapeutic Interventions for COVID-19
22:49
Quantify Potency of Therapeutics Targeting the SIRPα|CD47 Signaling Axis
Eurofins DiscoverX
Quantify Potency of Therapeutics Targeting the SIRPα|CD47 Signaling Axis
20:34
Eurofins DiscoverX Custom Capabilites
Eurofins DiscoverX
Eurofins DiscoverX Custom Capabilites
23:09
Accelerating COVID-19 Drug Discovery: Qualified Assays for Proinflammatory Cytokines
Eurofins DiscoverX
Accelerating COVID-19 Drug Discovery: Qualified Assays for Proinflammatory Cytokines
42:13
COVID-19 Drug Discovery with Qualified Cell-Based Assays for Proinflammatory Cytokines
Eurofins DiscoverX
COVID-19 Drug Discovery with Qualified Cell-Based Assays for Proinflammatory Cytokines
24:50
Eurofins DiscoverX Internalization Assays
Eurofins DiscoverX
Eurofins DiscoverX Internalization Assays
12:58
InCELL Compound-Target Engagement Assays for Drug Discovery
Eurofins DiscoverX
InCELL Compound-Target Engagement Assays for Drug Discovery
27:14
Cell Banking for Bioassays
Eurofins DiscoverX
Cell Banking for Bioassays
21:10
Simple Signaling Reporter Assays – Easily Quantify Activation & Inhibition of Cellular Pathways
Eurofins DiscoverX
Simple Signaling Reporter Assays – Easily Quantify Activation & Inhibition of Cellular Pathways
35:13
Detection of Protein Turnover Induced by Targeted Degraders
Eurofins DiscoverX
Detection of Protein Turnover Induced by Targeted Degraders
20:25
Eurofins DiscoverX Pharmacotrafficking Assay
Eurofins DiscoverX
Eurofins DiscoverX Pharmacotrafficking Assay
30:58
Eurofins DiscoverX GPCR Assays
Eurofins DiscoverX
Eurofins DiscoverX GPCR Assays
31:06
DiscoverX Cytotoxicity CD16 Effector Cells
Eurofins DiscoverX
DiscoverX Cytotoxicity CD16 Effector Cells
28:32
DiscoverX Cytotoxicity Cell-Based Assays
Eurofins DiscoverX
DiscoverX Cytotoxicity Cell-Based Assays
25:26
DiscoverX Checkpoint Receptor Cell-Based Assays
Eurofins DiscoverX
DiscoverX Checkpoint Receptor Cell-Based Assays
28:13
Eurofins DiscoverX: Biosensor Development Using CRISPR
Eurofins DiscoverX
Eurofins DiscoverX: Biosensor Development Using CRISPR
20:33
BioMAP® Human Phenotypic Profiling Services
Eurofins DiscoverX
BioMAP® Human Phenotypic Profiling Services
2:47
Eurofins Discovery Services
Eurofins DiscoverX
Eurofins Discovery Services
1:05:12
Accelerating Biologics & Biosimilars Development: Case Studies for Potency Bioassays
Eurofins DiscoverX
Accelerating Biologics & Biosimilars Development: Case Studies for Potency Bioassays
49:31
Building Relevant Cell Based Assays for Co Stimulatory & Co Inhibitory Checkpoint Receptors
Eurofins DiscoverX
Building Relevant Cell Based Assays for Co Stimulatory & Co Inhibitory Checkpoint Receptors
43:19
Ready to use Potency Assays for Anti VEGF Drugs Like Bevacizumab, Ranibizumab & Aflibercept
Eurofins DiscoverX
Ready to use Potency Assays for Anti VEGF Drugs Like Bevacizumab, Ranibizumab & Aflibercept
44:09
Application of β Arrestin Assays to the Orphan GPCR World
Eurofins DiscoverX
Application of β Arrestin Assays to the Orphan GPCR World
29:15
Combining Target Based and Phenotypic Discovery Assays for Drug Repurposing
Eurofins DiscoverX
Combining Target Based and Phenotypic Discovery Assays for Drug Repurposing
33:27
How to Accelerate Your Biotherapeutic Development with Cell-Based Assay Services
Eurofins DiscoverX
How to Accelerate Your Biotherapeutic Development with Cell-Based Assay Services
38:39
KILR CD16 Effector Cells
Eurofins DiscoverX
KILR CD16 Effector Cells
21:24
Create Your Own Cell-Based Assays to Study Receptor Tyrosine Kinase Function
Eurofins DiscoverX
Create Your Own Cell-Based Assays to Study Receptor Tyrosine Kinase Function
28:38
BioMAPが今アツイ!　医療抗体などが騒がれている中で、低分子化合物も活躍!
Eurofins DiscoverX
BioMAPが今アツイ!　医療抗体などが騒がれている中で、低分子化合物も活躍!
47:05
Discovery of Bacterial Effectors in the Human Microbiome and Isolation of a GPCR G2AGPR132 Agonist
Eurofins DiscoverX
Discovery of Bacterial Effectors in the Human Microbiome and Isolation of a GPCR G2AGPR132 Agonist
40:10
Driving Robust ADCC and T Cell Redirection with KILR CD16 Effector Cells
Eurofins DiscoverX
Driving Robust ADCC and T Cell Redirection with KILR CD16 Effector Cells
33:43
A Phenotypic Platform for Characterization of Drug Safety Mechanisms
Eurofins DiscoverX
A Phenotypic Platform for Characterization of Drug Safety Mechanisms
48:58
SAFETYscan オフターゲット効果を機能アッセイで同定,GPCR・チャネル・キナーゼ等を一気にスクリーニング
Eurofins DiscoverX
SAFETYscan オフターゲット効果を機能アッセイで同定,GPCR・チャネル・キナーゼ等を一気にスクリーニング
39:29
Create Your Own Cellular Compound Target Engagement Assay - May 18, 2017
Eurofins DiscoverX
Create Your Own Cellular Compound Target Engagement Assay - May 18, 2017
43:25
Combining Target Based and Phenotypic Discovery Assays for Drug Repurposing
Eurofins DiscoverX
Combining Target Based and Phenotypic Discovery Assays for Drug Repurposing
25:36
Allosteric Modulators of GPCRs - Drug Discovery Education
Eurofins DiscoverX
Allosteric Modulators of GPCRs - Drug Discovery Education
6:00
Mu Opioid Receptor Splicing and Signaling: Another Dimension of GPCR Function
Eurofins DiscoverX
Mu Opioid Receptor Splicing and Signaling: Another Dimension of GPCR Function
57:41
From Chemistry to Clinic: Discovery of Biased Apelin Receptor Agonists in Cardiovascular System
Eurofins DiscoverX
From Chemistry to Clinic: Discovery of Biased Apelin Receptor Agonists in Cardiovascular System
46:52
Creating Cellular Target Engagement Assays for Diverse Kinases Using InCELL Pulse
Eurofins DiscoverX
Creating Cellular Target Engagement Assays for Diverse Kinases Using InCELL Pulse
33:47
Target to Phenotype: Tools to Accelerate Your Immuno-Oncology Drug Pipeline
Eurofins DiscoverX
Target to Phenotype: Tools to Accelerate Your Immuno-Oncology Drug Pipeline
1:03:57
Immuno-Oncology Drug Development Profiling Immunomodulatory Biologics and Compounds
Eurofins DiscoverX
Immuno-Oncology Drug Development Profiling Immunomodulatory Biologics and Compounds
56:37
Create Your Own InCELL Pulse Cellular Compound Target Engagement Assay
Eurofins DiscoverX
Create Your Own InCELL Pulse Cellular Compound Target Engagement Assay
52:03
免疫チェックポイント阻害剤の評価に適切なセルベースアッセイ系のご紹介
Eurofins DiscoverX
免疫チェックポイント阻害剤の評価に適切なセルベースアッセイ系のご紹介
45:02
How to Make Your Own Cell-Based Assays to Study β-Arrestin Recruitment
Eurofins DiscoverX
How to Make Your Own Cell-Based Assays to Study β-Arrestin Recruitment
30:02
Unlocking GPCRs for Oncology Webinar
Eurofins DiscoverX
Unlocking GPCRs for Oncology Webinar
36:11
The Interplay of Kinase Broad Profiling and Phenotypic Screening
Eurofins DiscoverX
The Interplay of Kinase Broad Profiling and Phenotypic Screening
30:31
Duplexed Screening of GPCRs to Measure Calcium and β-Arrestin
Eurofins DiscoverX
Duplexed Screening of GPCRs to Measure Calcium and β-Arrestin
56:17
New Tricks for Old Drugs: An Unbiased Phenotypic Approach to Drug Repurposing
Eurofins DiscoverX
New Tricks for Old Drugs: An Unbiased Phenotypic Approach to Drug Repurposing
25:27
Phenotypic Platform for Characterization of Drug Safety Mechanisms in Human Models
Eurofins DiscoverX
Phenotypic Platform for Characterization of Drug Safety Mechanisms in Human Models
48:58
Enabling Development of Cancer Immunotherapy Drugs – From Discovery to Combination Strategies
Eurofins DiscoverX
Enabling Development of Cancer Immunotherapy Drugs – From Discovery to Combination Strategies
57:30